DrugDashboards

Vancomycin Hydrochloride

vancomycin hydrochloride · VANCOMYCIN HYDROCHLORIDE 10.25 g/g · Injection, Powder, For Solution · Intravenous; Oral · Hikma Pharmaceuticals Usa Inc.

NDC 00143-9164-01 · 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 10.25 g in 1 VIAL, PHARMACY BULK PACKAGE · NDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$55.00
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.017
HCPCS J3376 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$113,424
2,507 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for vancomycin hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA210274
TE code
—
Approval date
Jan 20, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of vancomycin hydrochloride (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 10 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN HYDROCHLORIDE 5 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 769 mg/mgJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 10.25 g/gJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 1280 mg/mgJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 1540 mg/mgJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 5.13 g/gJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 513 mg/mgJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals Usa Inc.VANCOMYCIN HYDROCHLORIDE 1025 mg/mgJul 15, 2026Sep 2, 2026
Zhejiang Novus Pharma Co., Ltd.VANCOMYCIN HYDROCHLORIDE 10.25 g/gJul 15, 2026Sep 2, 2026
Avenacy, LLCVANCOMYCIN HYDROCHLORIDE 1.5 g/1Aug 18, 2026Sep 1, 2026
Avenacy, LLCVANCOMYCIN HYDROCHLORIDE 750 mg/1Aug 18, 2026Sep 1, 2026
Avenacy, LLCVANCOMYCIN HYDROCHLORIDE 1.25 g/1Aug 18, 2026Sep 1, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vancomycin Hydrochloride — NDC 00143-9164-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00143916401.

Free to cite with attribution — see how the data is put together.